CASP3 and melanoma: Results obtained by Park et al. (2013) suggest that the treatment of malignant melanoma cells (harbouring mutation V600E and resistance to B-RAF inhibitors) with a combination of B-RAF – PLX4032 and MEK – AS-703026 inhibitors significantly induced apoptosis and caspase-3 expression.